Literatur
- 1
Schlegel U, Schmidt-Wolf I G, Deckert M.
Primary CNS lymphoma: clinical presentation, pathological classification, molecular
pathogenesis and treatment.
J Neurol Sci.
2000;
181
1-12
- 2
Nelson D F.
Radiotherapy in the treatment of primary central nervous system lymphoma (PCNSL).
J Neurooncol.
1999;
43
241-247
- 3
Herrlinger U, Schabet M, Brugger W. et al .
German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent
high-dose methotrexate for primary central nervous system lymphoma.
Ann Neurol.
2002;
51
247-252
- 4
Schlegel U, Pels H, Glasmacher A. et al .
Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: a pilot
study.
J Neurol Neurosurg Psychiatry.
2001;
71
118-122
- 5
Abrey L E, DeAngelis L M, Yahalom J.
Long-term survival in primary CNS lymphoma.
J Clin Oncol.
1998;
16
859-863
- 6
Herrlinger U, Brugger W, Bamberg M. et al .
PCV salvage chemotherapy for recurrent primary CNS lymphoma.
Neurology.
2000;
54
1707-1708
Prof. Dr. med. U. Schlegel
Neurologische Universitätsklinik
Sigmund-Freud-Straße 25
53105 Bonn
